Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:03 PM UTC
| NCT Number | NCT03909412 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Hackensack Meridian Health |
| Last Updated on CT.gov | September 21, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT03909412 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Hackensack Meridian Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03909412 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03909412 was last updated 3 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.